Related Experiment Video
Updated: Apr 12, 2026

07:13
A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
Published on: May 7, 2018
11.0K
eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells
Xing Hua Tang1, Xun Yi Wu1, Lan Xu1
1Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Plos One
|May 12, 2015
Summary
Glutamate increases P-glycoprotein expression in rat brain cells, but the eukaryote elongation factor-2 kinase (eEF-2K) inhibitor NH125 reduces it. NH125 shows potential as an anti-multidrug resistance agent.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- P-glycoprotein (P-gp) is a key efflux transporter in the blood-brain barrier.
- Regulation of P-gp expression is crucial for drug delivery and multidrug resistance.
- The role of glutamate and the eEF-2K pathway in P-gp regulation is not fully understood.
Purpose of the Study:
- To investigate the role of glutamate, NMDA receptors, and the eEF-2K/eEF-2 pathway in regulating P-glycoprotein expression.
- To evaluate the effect of the eEF-2K inhibitor NH125 on P-glycoprotein expression in rat brain microvessel endothelial cells (RBMECs).
Main Methods:
- Primary RBMECs were isolated from newborn Wistar rat brains.
- Cell viability was assessed using MTT assay.
- Expression levels of Mdr1a mRNA, P-glycoprotein, phospho-eEF-2, and eEF-2 were determined by RT-PCR and Western blot analysis.
Main Results:
- L-glutamate stimulation led to increased Mdr1a mRNA and P-glycoprotein expression in RBMECs.
- NH125 treatment significantly down-regulated P-glycoprotein and phospho-eEF-2 expression in glutamate-stimulated RBMECs.
- These findings suggest a role for the eEF-2K/eEF-2 pathway in modulating P-gp levels.
Conclusions:
- The eEF-2K/eEF-2 pathway plays a significant role in regulating P-glycoprotein expression in RBMECs.
- The eEF-2K inhibitor NH125 demonstrates potential as an effective agent against multidrug resistance.

